Journal profile · UROLOGY & NEPHROLOGY
Research and Reports in Urology
ISSN 2253-2447 · Dove Medical Press · United Kingdom
Research and Reports in Urology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.5 (journal website); JCR Q2 (journal website); fully open access; APC about USD 3,940; median 88 days to acceptance (98 articles, last 24 months); acceptance rate 37% (journal website); 48 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Research and Reports in Urology is published by Dove Medical Press and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Urinary Bladder and Prostate Research, Prostate Cancer Diagnosis and Treatment and Pelvic floor disorders treatments, together about 28.6% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Editor-in-Chief: Dr Panagiotis Vlachostergios Research and Reports in Urology is an international, peer-reviewed, open access, online journal. Research and Reports in Urology will no longer consider meta-analyses for publication. Publishing original research, reports, editorials, reviews and commentaries on all aspects of adult and pediatric urology in the clinic and laboratory including the following topics: Pathology, pathophysiology of urological disease Investigation and treatment of urological disease Pharmacology of drugs used for the treatment of urological disease Although the main focus of the journal is to publish research and clinical results in humans; preclinical, animal and in vitro studies will be published where they will shed light on disease processes and potential new therapies. Issues of patient safety and quality of care will also be considered. Updated 6 August 2025
From the journal's Aims & Scope
Research area (LetPub): UROLOGY & NEPHROLOGY
Editor-in-chief Panagiotis VlachostergiosPublisher website
Editorial board by country: none in mainland China; most named Italy 10, United States 5, Germany 2, Australia 2, Sweden 2 (33 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Urinary Bladder and Prostate ResearchMedicine12.5%
- Prostate Cancer Diagnosis and TreatmentMedicine8.8%
- Pelvic floor disorders treatmentsMedicine7.3%
- Urological Disorders and TreatmentsMedicine7.2%
- Kidney Stones and Urolithiasis TreatmentsMedicine6.7%
- Bladder and Urothelial Cancer TreatmentsMedicine6.2%
- Urinary Tract Infections ManagementMedicine6.2%
- Prostate Cancer Treatment and ResearchMedicine5.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Urology & Nephrology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Urology & Nephrology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · best quartile · 2025
- CiteScore Q1 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
SJR, CiteScore, Impact FactorPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 2.5Publisher website ·
- 5-year impact factor (publisher)
- 5Publisher website ·
- CiteScore 2026-06
- 5LetPub ·
- CiteScore (publisher) 2025
- 1.29Publisher website ·
- SJR 2026-06
- 0.86LetPub ·
- SNIP 2026-06
- 1.29LetPub ·
- h-index
- 40OpenAlex ·
- i10-index
- 223OpenAlex ·
- 2-year mean citedness
- 1.56OpenAlex ·
- Self-citation rate
- 4.2%LetPub ·
- Share of gold OA articles
- 98.57%LetPub ·
Volume
- Articles per year
- 47LetPub ·
- Downloads per year (publisher)
- 162,074Publisher website ·
Articles by year OpenAlex count · 718 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 49 | 49 | 2 |
| 2025 | 48 | 48 | 78 |
| 2024 | 34 | 34 | 124 |
| 2023 | 59 | 59 | 368 |
| 2022 | 44 | 44 | 629 |
| 2021 | 106 | 106 | 1,081 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
88 daysMedian, submission to acceptance · P25–P75 64 days – 109 days
- Acceptance to online
- median 11 days (98 articles)
- Submission to online
- median 99 days
- Sample
- 98 articles with submission and acceptance dates (109 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 16 weeksLetPub ·
- Acceptance rate (publisher)
- 37%Publisher website ·
- Desk decision
- 36 daysPublisher website ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,940 | Yes | CC BY, CC BY-NC | |
| OpenAlex | USD 2,320 | — | — | |
| LetPub | USD 2,990 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted4
- case reportAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
- clinical trial reportClinical Trial ReportLength not stated
- original researchOriginal ResearchLength not stated
- reviewAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
Policy excerpts from the journal's websitePublication ethics, Peer review
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Dove Medical Press
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2253-2447
- Official links
- Journal homepage ↗DOAJ
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Research and Reports in Urology
What CAS zone is Research and Reports in Urology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Research and Reports in Urology is in Zone 4 of Medicine, and in Zone 4 of the minor category Urology & Nephrology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Research and Reports in Urology?
The journal's website gives an impact factor of 2.5 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 5, h-index 40.
How long does peer review take at Research and Reports in Urology?
Based on the dates recorded on 98 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 88 days (interquartile range 64–109 days); authors report an average review time of about 16 weeks; the journal's website gives an acceptance rate of 37%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Research and Reports in Urology in?
The journal's website gives JCR Q2 (best quartile). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Where are the editorial board members of Research and Reports in Urology based?
Of the 33 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Italy (10), United States (5) and Germany (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Research and Reports in Urology?
According to LetPub and DOAJ records, Research and Reports in Urology is indexed in ESCI, Scopus and DOAJ.
Is Research and Reports in Urology open access, and what is the APC?
Research and Reports in Urology is a fully open-access journal. APC about USD 3,940.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .